Literature DB >> 18641161

Isolation of sabin-like polioviruses from wastewater in a country using inactivated polio vaccine.

Sebastian Zurbriggen1, Kurt Tobler, Carlos Abril, Sabine Diedrich, Mathias Ackermann, Mark A Pallansch, Alfred Metzler.   

Abstract

From 2001 to 2004, Switzerland switched from routine vaccination with oral polio vaccine (OPV) to inactivated polio vaccine (IPV), using both vaccines in the intervening period. Since IPV is less effective at inducing mucosal immunity than OPV, this change might allow imported poliovirus to circulate undetected more easily in an increasingly IPV-immunized population. Environmental monitoring is a recognized tool for identifying polioviruses in a community. To look for evidence of poliovirus circulation following cessation of OPV use, two sewage treatment plants located in the Zurich area were sampled from 2004 to 2006. Following virus isolation using either RD or L20B cells, enteroviruses and polioviruses were identified by reverse transcription-PCR. A total of 20 out of 174 wastewater samples were positive for 62 Sabin-like isolates. One isolate from each poliovirus-positive sample was analyzed in more detail. Sequencing the complete viral protein 1 (VP1) capsid coding region, as well as intratypic differentiation (ITD), identified 3 Sabin type 1, 13 Sabin type 2, and 4 Sabin type 3 strains. One serotype 1 strain showed a discordant result in the ITD. Three-quarters of the strains showed mutations within the 5' untranslated region and VP1, known to be associated with reversion to virulence. Moreover, three strains showed heterotypic recombination (S2/S1 and S3/S2/S3). The low number of synonymous mutations and the partial temperature sensitivity are not consistent with extended circulation of these Sabin virus strains. Nevertheless, the continuous introduction of polioviruses into the community emphasizes the necessity for uninterrupted child vaccination to maintain high herd immunity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641161      PMCID: PMC2547022          DOI: 10.1128/AEM.02764-07

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  59 in total

1.  Reevaluation of nucleotide sequences of wild-type and attenuated polioviruses of type 3.

Authors:  G V Rezapkin; M Douthitt; E Dragunsky; K M Chumakov
Journal:  Virus Res       Date:  1999-12-15       Impact factor: 3.303

2.  Immunity to poliomyelitis in The Netherlands.

Authors:  M A Conyn-Van Spaendonck; H E de Melker; F Abbink; N Elzinga-Gholizadea; T G Kimman; T van Loon
Journal:  Am J Epidemiol       Date:  2001-02-01       Impact factor: 4.897

3.  Stopping poliovirus vaccination after eradication: issues and challenges.

Authors:  D J Wood; R W Sutter; W R Dowdle
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

4.  Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model.

Authors:  G V Gavrilin; E A Cherkasova; G Y Lipskaya; O M Kew; V I Agol
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Persistence of viral pathogens and bacteriophages during sewage treatment: lack of correlation with indicator bacteria.

Authors:  F Baggi; A Demarta; R Peduzzi
Journal:  Res Microbiol       Date:  2001-10       Impact factor: 3.992

Review 6.  Poliovirus and poliomyelitis: a tale of guts, brains, and an accidental event.

Authors:  Steffen Mueller; Eckard Wimmer; Jeronimo Cello
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

7.  Genomic features of intertypic recombinant sabin poliovirus strains excreted by primary vaccinees.

Authors:  N S Cuervo; S Guillot; N Romanenkova; M Combiescu; A Aubert-Combiescu; M Seghier; V Caro; R Crainic; F Delpeyroux
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

8.  Natural genetic exchanges between vaccine and wild poliovirus strains in humans.

Authors:  S Guillot; V Caro; N Cuervo; E Korotkova; M Combiescu; A Persu; A Aubert-Combiescu; F Delpeyroux; R Crainic
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

9.  Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.

Authors:  Gabriele Buttinelli; Valentina Donati; Stefano Fiore; Jill Marturano; Alessandro Plebani; Paolo Balestri; Anna Rosa Soresina; Rossella Vivarelli; Francis Delpeyroux; Javier Martin; Lucia Fiore
Journal:  J Gen Virol       Date:  2003-05       Impact factor: 3.891

10.  Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.

Authors:  Elena A Cherkasova; Ekaterina A Korotkova; Maria L Yakovenko; Olga E Ivanova; Tatyana P Eremeeva; Konstantin M Chumakov; Vadim I Agol
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more
  22 in total

1.  Community circulation patterns of oral polio vaccine serotypes 1, 2, and 3 after Mexican national immunization weeks.

Authors:  Stephanie B Troy; Leticia Ferreyra-Reyes; Chunhong Huang; Clea Sarnquist; Sergio Canizales-Quintero; Christine Nelson; Renata Báez-Saldaña; Marisa Holubar; Elizabeth Ferreira-Guerrero; Lourdes García-García; Yvonne A Maldonado
Journal:  J Infect Dis       Date:  2013-12-23       Impact factor: 5.226

2.  Detection of Enteroviruses in Water Samples from Yopougon, Côte d'Ivoire by Cell Culture and Polymerase Chain Reaction.

Authors:  K J Momou; C Akoua-Koffi; M Dosso
Journal:  Food Environ Virol       Date:  2013-11-02       Impact factor: 2.778

3.  Environmental Surveillance of Non-polio Enteroviruses in Poland, 2011.

Authors:  Magdalena Wieczorek; Agnieszka Ciąćka; Agnieszka Witek; Łukasz Kuryk; Anna Żuk-Wasek
Journal:  Food Environ Virol       Date:  2015-04-11       Impact factor: 2.778

4.  Sporadic isolation of sabin-like polioviruses and high-level detection of non-polio enteroviruses during sewage surveillance in seven Italian cities, after several years of inactivated poliovirus vaccination.

Authors:  A Battistone; G Buttinelli; S Fiore; C Amato; P Bonomo; A M Patti; A Vulcano; M Barbi; S Binda; L Pellegrinelli; M L Tanzi; P Affanni; P Castiglia; C Germinario; P Mercurio; A Cicala; M Triassi; F Pennino; L Fiore
Journal:  Appl Environ Microbiol       Date:  2014-08       Impact factor: 4.792

5.  Poliovirus and Other Enteroviruses from Environmental Surveillance in Italy, 2009-2015.

Authors:  Roberto Delogu; Andrea Battistone; Gabriele Buttinelli; Stefano Fiore; Stefano Fontana; Concetta Amato; Karen Cristiano; Sabine Gamper; Josef Simeoni; Rita Frate; Laura Pellegrinelli; Sandro Binda; Licia Veronesi; Roberta Zoni; Paolo Castiglia; Andrea Cossu; Maria Triassi; Francesca Pennino; Cinzia Germinario; Viviana Balena; Antonella Cicala; Pietro Mercurio; Lucia Fiore; Carlo Pini; Paola Stefanelli
Journal:  Food Environ Virol       Date:  2018-06-12       Impact factor: 2.778

6.  The double-edged sword: How evolution can make or break a live-attenuated virus vaccine.

Authors:  Kathryn A Hanley
Journal:  Evolution (N Y)       Date:  2011-12

7.  Laboratory Surveillance of Polio and Other Enteroviruses in High-Risk Populations and Environmental Samples.

Authors:  Vasiliki Pogka; Stavroula Labropoulou; Mary Emmanouil; Androniki Voulgari-Kokota; Alexandra Vernardaki; Theano Georgakopoulou; Andreas F Mentis
Journal:  Appl Environ Microbiol       Date:  2017-02-15       Impact factor: 4.792

8.  Interaction of Paramecium caudatum and Picornaviruses.

Authors:  Z A Karalyan; H E Voskanyan; N V Ramazyan; H S Zakaryan; E M Karalova
Journal:  Indian J Virol       Date:  2012-09-18

9.  Exposure factors for wastewater-irrigated Asian vegetables and a probabilistic rotavirus disease burden model for their consumption.

Authors:  Hoi-Fei Mok; Andrew J Hamilton
Journal:  Risk Anal       Date:  2014-02-27       Impact factor: 4.000

10.  Development of a multiplex RT-PCR assay for the identification of recombination types at different genomic regions of vaccine-derived polioviruses.

Authors:  T G Dimitriou; Z Kyriakopoulou; D Tsakogiannis; A Fikatas; C Gartzonika; S Levidiotou-Stefanou; P Markoulatos
Journal:  Virus Genes       Date:  2016-04-20       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.